CenterBook Partners LP lifted its stake in Enovix Corporation (NASDAQ:ENVX – Free Report) by 66.1% in the 4th quarter, Holdings Channel.com reports. The firm owned 1,757,382 shares of the company’s stock after purchasing an additional 699,519 shares during the period. CenterBook Partners LP’s holdings in Enovix were worth $12,846,000 at the end of the most recent reporting period.
Other hedge funds and other institutional investors have also recently made changes to their positions in the company. Caitlin John LLC acquired a new stake in shares of Enovix in the third quarter valued at approximately $27,000. Parallel Advisors LLC grew its position in Enovix by 51.9% in the third quarter. Parallel Advisors LLC now owns 3,926 shares of the company’s stock worth $39,000 after acquiring an additional 1,342 shares during the period. CWM LLC grew its position in Enovix by 95.4% in the fourth quarter. CWM LLC now owns 6,081 shares of the company’s stock worth $44,000 after acquiring an additional 2,969 shares during the period. Wilmington Savings Fund Society FSB purchased a new position in Enovix in the third quarter worth approximately $80,000. Finally, Bowman & Co S.C. purchased a new position in Enovix in the fourth quarter worth approximately $73,000. Institutional investors and hedge funds own 50.92% of the company’s stock.
Wall Street Analyst Weigh In
Several research analysts recently weighed in on ENVX shares. Benchmark lowered their price objective on Enovix from $25.00 to $15.00 and set a “buy” rating for the company in a research report on Thursday, May 14th. B. Riley Financial lowered their price objective on Enovix from $17.00 to $10.00 and set a “buy” rating for the company in a research report on Monday, March 2nd. Wall Street Zen upgraded Enovix from a “strong sell” rating to a “sell” rating in a research report on Saturday, May 16th. Canaccord Genuity Group lowered their price objective on Enovix from $21.00 to $15.00 and set a “buy” rating for the company in a research report on Thursday, February 26th. Finally, Wells Fargo & Company set a $6.00 price objective on Enovix in a research report on Thursday, March 12th. Seven research analysts have rated the stock with a Buy rating, one has assigned a Hold rating and two have assigned a Sell rating to the company’s stock. Based on data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and an average price target of $12.64.
Enovix Stock Performance
ENVX opened at $7.28 on Monday. Enovix Corporation has a 52 week low of $4.61 and a 52 week high of $16.49. The business has a fifty day simple moving average of $6.50 and a 200-day simple moving average of $6.78. The firm has a market cap of $1.59 billion, a P/E ratio of -8.77 and a beta of 2.27. The company has a quick ratio of 10.65, a current ratio of 10.97 and a debt-to-equity ratio of 2.14.
Enovix (NASDAQ:ENVX – Get Free Report) last released its quarterly earnings results on Wednesday, May 13th. The company reported ($0.14) EPS for the quarter, topping the consensus estimate of ($0.15) by $0.01. Enovix had a negative return on equity of 64.28% and a negative net margin of 499.64%.The business had revenue of $7.60 million during the quarter, compared to analyst estimates of $6.95 million. During the same period last year, the business posted ($0.15) earnings per share. The company’s quarterly revenue was up 49.1% on a year-over-year basis. Enovix has set its Q2 2026 guidance at -0.170–0.130 EPS. On average, equities analysts expect that Enovix Corporation will post -0.79 earnings per share for the current year.
Enovix Company Profile
Enovix Corporation (NASDAQ: ENVX) develops and manufactures advanced lithium-ion battery cells with a patented three-dimensional silicon-anode architecture. The company’s core focus is on delivering high energy density, improved safety, and longer cycle life compared to conventional graphite-based cells. Enovix’s technology targets a range of applications, including consumer electronics, wearable devices, electric vehicles and stationary energy storage systems.
Founded in 2011 and headquartered in Fremont, California, Enovix has built pilot production capability and is scaling up manufacturing capacity to meet growing demand.
Featured Stories
- Five stocks we like better than Enovix
- These 3 Insurance Stocks Made New 52-Week Highs: Still Time to Buy?
- 3 Stocks Under $20 to Buy Before a Broader Market Rally
- Petco Faces Tough Competition, But Momentum Is Building
- The Lock-In Effect Is Real—These 3 Homebuilders Are Betting on It
Want to see what other hedge funds are holding ENVX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Enovix Corporation (NASDAQ:ENVX – Free Report).
Receive News & Ratings for Enovix Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Enovix and related companies with MarketBeat.com's FREE daily email newsletter.
